![Open access](/images/ico/o.png)
![](/images/ico/ico5.png)
Author: Hashimoto Motomu
Publisher: MDPI
E-ISSN: 2077-0383|6|7|73-73
ISSN: 2077-0383
Source: Journal of Clinical Medicine, Vol.6, Iss.7, 2017-07, pp. : 73-73
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/o.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab: In Rheumatoid Arthritis
By Frampton James E. Scott Lesley J.
BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abatacept for rheumatoid arthritis
By Rojahn Ruth
International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Certolizumab Pegol: In Rheumatoid Arthritis
By Duggan Sean T. Keam Susan J.
BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. :